Skip to main content

Find Clinical Trials

Home
Conditions
Hyperphosphatemia

Clinical trial condition

Hyperphosphatemia

Explore clinical trials studying Hyperphosphatemia. Study availability and eligibility vary by location and protocol.

95 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hyperphosphatemia trial results

Completed

DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis

NCT03305471

Conditions: Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations: DaVita Clinical Research Lakewood, Colorado, United States

Orlando Clinical Research Center Orlando, Florida, United States

DaVita Clinical Research Minneapolis, Minnesota, United States

Prism Clinical Research Saint Paul, Minnesota, United States

View Trial Details

Completed

A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia

NCT01850602

Conditions: Hemodialysis, Hyperphosphatemia, Metabolic Diseases, +2 more
Locations: Multiple Locations, Japan

View Trial Details

Completed

A Phase III Study of PA21 With Calcium Carbonate in Hemodialysis Patients With Hyperphosphatemia

NCT01850641

Conditions: Hemodialysis, Hyperphosphatemia, Metabolic Diseases, +2 more
Locations: Multiple Locations, Japan

View Trial Details

Completed

Low-Phosphate Diet and Fibroblast Growth Factor-23 Level

NCT03367338

Conditions: Chronic Kidney Disease Requiring Chronic Dialysis, Dietary Intervention, Elevated Fibroblast Growth Factor-23, +4 more
Locations: Far Eastern Memorial Hospital New Taipei City, Taiwan

View Trial Details

Completed

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

NCT02965053

Conditions: Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations: Indianapolis, Indiana, United States

View Trial Details

Completed

Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D

NCT02492620

Conditions: Anemia, Anemia, Hypochromic, Anemia, Iron-Deficiency, +22 more
Locations: Denver Nephrologists, P.C. Denver, Colorado, United States

View Trial Details

Completed

Behavioral Management of Phosphorus in Hemodialysis Patients

NCT02940743

Conditions: Cardiovascular Disease (CKD), Cardiovascular Diseases, Hyperphosphatemia, +3 more
Locations: New York University School of Medicine New York, United States

View Trial Details

Completed

Study of Individualized Therapy on Hyperphosphatemia in Maintenance Hemodialysis Patients

NCT02684643

Conditions: Chronic Disease, Disease Attributes, End-stage Renal Disease, +15 more
Locations: Huashan Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Completed

Fosrenol Post-marketing Surveillance in Japan

NCT01955876

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperphosphatemia, +8 more
Locations: Multiple Locations, Japan

View Trial Details

Completed

Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in Japan

NCT01412398

Conditions: Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations: Multiple Locations, Japan

View Trial Details